CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-21 | BARKER SAM L Director | Exercise or conversion · Restricted Stock Units | −9,302 | 0 | ||
| 2023-05-21 | Amouyal Philippe Director | Exercise or conversion | +9,302 | 40,332 | ||
| 2023-05-21 | Amouyal Philippe Director | Exercise or conversion · Restricted Stock Units | −9,302 | 0 | ||
| 2023-04-28 | Swain Judith L Director | Grant or award · Restricted Stock Units | +8,032 | 8,032 | ||
| 2023-04-28 | Swain Judith L Director | Grant or award · Stock Option (Right to Buy) | +12,658 | 12,658 | ||
| 2023-04-28 | SOBECKI CHRISTOPHER J Director | Grant or award · Restricted Stock Units | +8,032 | 8,032 | ||
| 2023-04-28 | SOBECKI CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +12,658 | 12,658 | ||
| 2023-04-28 | Palantoni Frank Director | Grant or award · Restricted Stock Units | +8,032 | 8,032 | ||
| 2023-04-28 | Palantoni Frank Director | Grant or award · Stock Option (Right to Buy) | +12,658 | 12,658 | ||
| 2023-04-28 | NIES ALAN S Director | Grant or award · Restricted Stock Units | +8,032 | 8,032 | ||
| 2023-04-28 | NIES ALAN S Director | Grant or award · Stock Option (Right to Buy) | +12,658 | 12,658 | ||
| 2023-04-28 | LEFKOWITZ ROBERT J MD Director | Grant or award · Restricted Stock Units | +8,032 | 8,032 | ||
| 2023-04-28 | LEFKOWITZ ROBERT J MD Director | Grant or award · Stock Option (Right to Buy) | +12,658 | 12,658 | ||
| 2023-04-28 | DEBBANE RAYMOND Director | Grant or award · Restricted Stock Units | +8,032 | 8,032 | ||
| 2023-04-28 | DEBBANE RAYMOND Director | Grant or award · Stock Option (Right to Buy) | +12,658 | 12,658 | ||
| 2023-04-28 | BARKER SAM L Director | Grant or award · Restricted Stock Units | +8,032 | 8,032 | ||
| 2023-04-28 | BARKER SAM L Director | Grant or award · Stock Option (Right to Buy) | +12,658 | 12,658 | ||
| 2023-04-28 | Amouyal Philippe Director | Grant or award · Restricted Stock Units | +8,032 | 8,032 | ||
| 2023-04-28 | Amouyal Philippe Director | Grant or award · Stock Option (Right to Buy) | +12,658 | 12,658 | ||
| 2023-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion | +5,400 | 22,363 |
Page 17 of 27 · 540 trades